Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 5NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5CNS 5

Conditions

Ovarian Neoplasms 44Lung Neoplasms 29Neuroblastoma 24Small Cell Lung Carcinoma 21Carcinoma, Ovarian Epithelial 19Fallopian Tube Neoplasms 17Neoplasms 14Brain Neoplasms 14Uterine Cervical Neoplasms 11Leukemia, Myeloid, Acute 11Leukemia 11Retinoblastoma 10Glioma 9Recurrence 8Sarcoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma 7Central Nervous System Neoplasms 7Sarcoma, Ewing 6Neoplasm Metastasis 6Lymphoma, Follicular 6Unspecified Adult Solid Tumor, Protocol Specific 5Osteosarcoma 5Gliosarcoma 5Glioblastoma 5Endometrial Neoplasms 5Burkitt Lymphoma 5Blast Crisis 5Astrocytoma 5Wilms Tumor 4

Interventions

Temozolomide 264Radiotherapy 119Bevacizumab 105Magnetic Resonance Spectroscopy 59Radiation 47pembrolizumab 30Irinotecan 28Surgical Procedures, Operative 23Lomustine 21Specimen Handling 19Nivolumab 19Radiosurgery 18Carmustine 18Aminolevulinic Acid 16Erlotinib Hydrochloride 15Drug Therapy 15Blood Specimen Collection 14Radiotherapy, Intensity-Modulated 13O(6)-benzylguanine 13Chemotherapy, Adjuvant 13Carboplatin 13Filgrastim 11Cyclophosphamide 11sargramostim 10poly ICLC 10atezolizumab 10Thalidomide 10Etoposide 10Ipilimumab 9Everolimus 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Glioblastoma × Topotecan × Clear all
NCT00014443 2023-01-09

Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

Rush University Medical Center

Phase 2 Terminated
5 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01004874 2022-04-13

Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma

Duke University

Phase 2 Completed
80 enrolled 11 charts
CNSSarcoma

Glioblastoma, Glioma, Gliosarcoma

NCT00610571 2013-10-25

Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas

Duke University

Phase 1 Completed
62 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

NCT00002814 2011-10-27

Combination Chemotherapy for Patients With Brain Cancer

Dartmouth-Hitchcock Medical Center

Phase 2 Completed
20 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00541138 2011-09-21

Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors

City of Hope Medical Center

Phase 2 Completed
50 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Neoplasm Metastasis, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡